{"version":"1.0","provider_name":"Jordan News Gazette","provider_url":"https:\/\/jordannewsgazette.com","author_name":"jadmin","author_url":"https:\/\/jordannewsgazette.com\/author\/jadmin\/","title":"Insilico Medicine Appoints Michael Bayewitch as VP, Business Development and Strategy - Jordan News Gazette","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"BmD4xadeUU\"><a href=\"https:\/\/jordannewsgazette.com\/insilico-medicine-appoints-michael-bayewitch-as-vp-business-development-and-strategy\/\">Insilico Medicine Appoints Michael Bayewitch as VP, Business Development and Strategy<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/jordannewsgazette.com\/insilico-medicine-appoints-michael-bayewitch-as-vp-business-development-and-strategy\/embed\/#?secret=BmD4xadeUU\" width=\"600\" height=\"338\" title=\"&#8220;Insilico Medicine Appoints Michael Bayewitch as VP, Business Development and Strategy&#8221; &#8212; Jordan News Gazette\" data-secret=\"BmD4xadeUU\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n<\/script>\n","description":"Abu Dhabi, May 15, 2023 (GLOBE NEWSWIRE) \u2014 Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, has appointed Michael Bayewitch, PhD, as Vice President (VP) of Business Development and Strategy. Based on the U.S. West Coast, Dr. Bayewitch will work closely with Alex Zhavoronkov, PhD, founder and CEO, Feng Ren, PhD, Co-CEO [\u2026]","thumbnail_url":"https:\/\/ci6.googleusercontent.com\/proxy\/bhJiEv647bP_STvvnlmncbMj5IHhyjhHCxHYwVJi_ZD5u11-eaPUU70OftsuYTgklDRJKQGUlYoMzxaKn70oPRDg-ZagZe5wlGQ5TqB7w5eci25zcikvQ3jIAdmiKPlVmrYMcYYJKjrj4W8apxVea2d4bn-MXfS7flQx_yVlzbW3IKvj7ExRA8nepeCy=s0-d-e1-ft#https:\/\/ml.globenewswire.com\/media\/YmYzMDZiM2YtNWRkMC00YmZlLTg0N2EtZWFjZWVkYzlmODFhLTEwMjQ5MjE=\/tiny\/InSilico-Medicine.png"}